158 related articles for article (PubMed ID: 21515509)
41. The efficacy, tolerability and safety of levetiracetam therapy in a pediatric population.
Tekgül H; Gencpinar P; Çavuşoğlu D; Dündar NO
Seizure; 2016 Mar; 36():16-21. PubMed ID: 26874856
[TBL] [Abstract][Full Text] [Related]
42. Efficacy and tolerability of levetiracetam as adjunctive therapy in Japanese patients with uncontrolled partial-onset seizures.
Inoue Y; Yagi K; Ikeda A; Sasagawa M; Ishida S; Suzuki A; Yoshida K;
Psychiatry Clin Neurosci; 2015 Oct; 69(10):640-8. PubMed ID: 25854635
[TBL] [Abstract][Full Text] [Related]
43. Long-term experience with levetiracetam.
Abou-Khalil B; Lazenby B
Epileptic Disord; 2003 May; 5 Suppl 1():S33-7. PubMed ID: 12915339
[TBL] [Abstract][Full Text] [Related]
44. Levetiracetam.
Nash EM; Sangha KS
Am J Health Syst Pharm; 2001 Jul; 58(13):1195-9. PubMed ID: 11449876
[TBL] [Abstract][Full Text] [Related]
45. Levetiracetam: preliminary efficacy in generalized seizures.
Kasteleijn-Nolst Trenité DG; Hirsch E
Epileptic Disord; 2003 May; 5 Suppl 1():S39-44. PubMed ID: 12915340
[TBL] [Abstract][Full Text] [Related]
46. Newer antiepileptic drugs compared to levetiracetam as adjunctive treatments for uncontrolled focal epilepsy: An indirect comparison.
Zhu LN; Chen D; Xu D; Tan G; Wang HJ; Liu L
Seizure; 2017 Oct; 51():121-132. PubMed ID: 28854405
[TBL] [Abstract][Full Text] [Related]
47. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
48. [Are clinical features derived from evidences and experiences outside of Japan applicable to clinical practices in Japan? Comparisons of results among studies conducted in US, Europe, Asian Countries and Japan].
Kamada K
Brain Nerve; 2011 Mar; 63(3):247-54. PubMed ID: 21386126
[TBL] [Abstract][Full Text] [Related]
49. Levetiracetam for the treatment of neonatal seizures.
Shoemaker MT; Rotenberg JS
J Child Neurol; 2007 Jan; 22(1):95-8. PubMed ID: 17608315
[TBL] [Abstract][Full Text] [Related]
50. [Effectiveness and tolerability of the new antiepileptic drugs: the position of levetiracetam].
Arroyo S
Rev Neurol; 2002 Aug 1-15; 35(3):227-30. PubMed ID: 12235583
[TBL] [Abstract][Full Text] [Related]
51. Seizure-free days observed in randomized placebo-controlled add-on trials with levetiracetam in partial epilepsy.
Leppik I; Morrell M; Godfroid P; Arrigo C
Epilepsia; 2003 Oct; 44(10):1350-2. PubMed ID: 14510829
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and tolerability of levetiracetam for pediatric refractory epilepsy.
Muramatsu K; Sawaura N; Ogata T; Makioka N; Tomita K; Motojima T; Ida K; Hazama K; Arakawa H
Brain Dev; 2017 Mar; 39(3):231-235. PubMed ID: 27745925
[TBL] [Abstract][Full Text] [Related]
53. [Efficacy and safety of adjunctive levetiracetam in children younger than 4 years with refractory epilepsy].
Hu Y; Liao JX; Chen L; Huang TS; Li B
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Apr; 12(4):256-8. PubMed ID: 20416214
[TBL] [Abstract][Full Text] [Related]
54. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
Perry S; Holt P; Benatar M
J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
[TBL] [Abstract][Full Text] [Related]
55. [Experience with levetiracetam in childhood epilepsy].
Neuwirth M; Saracz J; Hegyi M; Paraicz E; Kollár K; Móser J; Rosdy B; Herczegfalvi A; Fogarasi A
Ideggyogy Sz; 2006 May; 59(5-6):179-82. PubMed ID: 16786712
[TBL] [Abstract][Full Text] [Related]
56. Behavioral side-effects of levetiracetam in children with epilepsy: a systematic review.
Halma E; de Louw AJ; Klinkenberg S; Aldenkamp AP; IJff DM; Majoie M
Seizure; 2014 Oct; 23(9):685-91. PubMed ID: 24981629
[TBL] [Abstract][Full Text] [Related]
57. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
[TBL] [Abstract][Full Text] [Related]
58. Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy.
Labiner DM; Ettinger AB; Fakhoury TA; Chung SS; Shneker B; Tatum Iv WO; Mitchell Miller J; Vuong A; Hammer AE; Messenheimer JA
Epilepsia; 2009 Mar; 50(3):434-42. PubMed ID: 19016830
[TBL] [Abstract][Full Text] [Related]
59. Potential of levetiracetam in mood disorders: a preliminary review.
Muralidharan A; Bhagwagar Z
CNS Drugs; 2006; 20(12):969-79. PubMed ID: 17140277
[TBL] [Abstract][Full Text] [Related]
60. The Effectiveness of Antiepileptic Medications as Prophylaxis of Early Seizure in Patients with Traumatic Brain Injury Compared with Placebo or No Treatment: A Systematic Review and Meta-Analysis.
Wat R; Mammi M; Paredes J; Haines J; Alasmari M; Liew A; Lu VM; Arnaout O; Smith TR; Gormley WB; Aglio LS; Mekary RA; Zaidi H
World Neurosurg; 2019 Feb; 122():433-440. PubMed ID: 30465951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
